Display options
Cite
Yu B, Shi L, Zhang BZ, et al. Obligate anaerobic . Oncol Lett. 2015;10(2):1069-1074doi: 10.3892/ol.2015.3302.
Yu, B., Shi, L., Zhang, B. Z., Zhang, K. E., Peng, X., Niu, H. B., & Qu, J. L. (2015). Obligate anaerobic . Oncology letters, 10(2), 1069-1074. https://doi.org/10.3892/ol.2015.3302
Yu, Bin, et al. "Obligate anaerobic ." Oncology letters vol. 10,2 (2015): 1069-1074. doi: https://doi.org/10.3892/ol.2015.3302
Yu B, Shi L, Zhang BZ, Zhang KE, Peng X, Niu HB, Qu JL. Obligate anaerobic . Oncol Lett. 2015 Aug;10(2):1069-1074. doi: 10.3892/ol.2015.3302. Epub 2015 Jun 02. PMID: 26622627; PMCID: PMC4509430.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2015 Aug;10(2):1069-1074. doi: 10.3892/ol.2015.3302. Epub 2015 Jun 02.

Obligate anaerobic .

Oncology letters

Bin Yu, Lei Shi, Bao-Zhong Zhang, K E Zhang, Xiao Peng, Han-Ben Niu, Jun-LE Qu

Affiliations

  1. Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, Shenzhen, Guangdong 518060, P.R. China ; Department of Biochemistry, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, SAR, P.R. China.
  2. Department of Biochemistry, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, SAR, P.R. China.
  3. Department of Microbiology, The University of Hong Kong, Pokfulam, Hong Kong, SAR, P.R. China.
  4. Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, Shenzhen, Guangdong 518060, P.R. China.

PMID: 26622627 PMCID: PMC4509430 DOI: 10.3892/ol.2015.3302

Abstract

The present authors have previously reported a novel approach to genetically engineer

Keywords: Salmonella; YB1 strain; bacterial cancer therapy; synthetic biology

References

  1. Semin Radiat Oncol. 2009 Apr;19(2):106-11 - PubMed
  2. Semin Radiat Oncol. 2004 Jul;14(3):198-206 - PubMed
  3. Cancer Res. 1998 Apr 1;58(7):1408-16 - PubMed
  4. Nat Rev Cancer. 2004 Jun;4(6):437-47 - PubMed
  5. Trends Immunol. 2003 Jun;24(6):335-42 - PubMed
  6. Curr Opin Genet Dev. 2001 Jun;11(3):293-9 - PubMed
  7. Genomics. 1995 Aug 10;28(3):549-59 - PubMed
  8. Sci Rep. 2012;2:436 - PubMed
  9. Cancer Res. 2006 Aug 1;66(15):7647-52 - PubMed
  10. Trends Immunol. 2003 Feb;24(2):58-61 - PubMed
  11. Cancer Res. 2007 Jan 15;67(2):563-72 - PubMed
  12. J Cell Physiol. 2003 Jun;195(3):346-55 - PubMed
  13. Cancer Res. 1997 Oct 15;57(20):4537-44 - PubMed
  14. Cancer Res. 2008 Oct 1;68(19):7995-8003 - PubMed
  15. Nat Immunol. 2004 Jan;5(1):7-10 - PubMed
  16. Cancer Gene Ther. 2000 Feb;7(2):269-74 - PubMed
  17. Science. 2013 Nov 22;342(6161):967-70 - PubMed
  18. Cancer Res. 2005 May 1;65(9):3920-7 - PubMed
  19. Lancet Oncol. 2003 Sep;4(9):548-56 - PubMed
  20. Nat Biotechnol. 1999 Jan;17(1):37-41 - PubMed
  21. Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14748-50 - PubMed
  22. Nat Rev Cancer. 2008 Dec;8(12):967-75 - PubMed
  23. Nature. 1981 May 21;291(5812):238-9 - PubMed
  24. Cancer Sci. 2010 Sep;101(9):1925-32 - PubMed
  25. Nat Rev Immunol. 2003 Aug;3(8):630-41 - PubMed
  26. Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):755-60 - PubMed
  27. Br J Cancer. 2006 Nov 6;95(9):1212-9 - PubMed
  28. Cancer Sci. 2009 Dec;100(12):2437-43 - PubMed
  29. Nat Med. 1999 Jun;5(6):677-85 - PubMed
  30. Breast Cancer Res Treat. 2001 Mar;66(2):165-70 - PubMed
  31. Am J Clin Oncol. 2001 Oct;24(5):458-61 - PubMed
  32. Cancer Sci. 2012 Feb;103(2):325-33 - PubMed
  33. J Immunother. 2002 May-Jun;25(3):218-25 - PubMed

Publication Types